171 related articles for article (PubMed ID: 10326705)
41. Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma.
Zorludemir S; Scheithauer BW; Hirose T; Van Houten C; Miller G; Meyer FB
Am J Surg Pathol; 1995 May; 19(5):493-505. PubMed ID: 7726360
[TBL] [Abstract][Full Text] [Related]
42. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM
Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
[TBL] [Abstract][Full Text] [Related]
43. Lack of alkaline phosphatase activity predicts meningioma recurrence.
Bouvier C; Liprandi A; Colin C; Giorgi R; Quilichini B; Metellus P; Figarella-Branger D
Am J Clin Pathol; 2005 Aug; 124(2):252-8. PubMed ID: 16040297
[TBL] [Abstract][Full Text] [Related]
44. Analysis of immunohistochemical expression of p53 and the proliferation marker Ki-67 antigen in skull base chordomas: relationships between their expression and prognosis.
Sakai K; Hongo K; Tanaka Y; Nakayama J
Brain Tumor Pathol; 2007; 24(2):57-62. PubMed ID: 18095132
[TBL] [Abstract][Full Text] [Related]
45. Expression of the proliferating cell nuclear antigen and clinicopathological features in intracranial meningiomas.
Kim CH; Cheong JH; Bak KH; Kim JM; Oh SJ
J Clin Neurosci; 2001 May; 8 Suppl 1():44-8. PubMed ID: 11386825
[TBL] [Abstract][Full Text] [Related]
46. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
47. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
48. Relationship between malignant subtypes of meningioma and clinical outcome.
Ko KW; Nam DH; Kong DS; Lee JI; Park K; Kim JH
J Clin Neurosci; 2007 Aug; 14(8):747-53. PubMed ID: 17499508
[TBL] [Abstract][Full Text] [Related]
49. Intracranial hemangiopericytomas: correlation of topoisomerase IIalpha expression with biologic behavior.
Chacko G; Chacko AG; Rajshekhar V; Muliyil JP
Surg Neurol; 2006 Jan; 65(1):11-7. PubMed ID: 16378841
[TBL] [Abstract][Full Text] [Related]
50. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma.
Ho DM; Hsu CY; Ting LT; Chiang H
Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512
[TBL] [Abstract][Full Text] [Related]
51. The prognostic importance of nuclear morphometry and the MIB-1 index in rhabdomyosarcoma [corrected].
Noguchi S; Tamiya S; Nagoshi M; Suita S; Fukuda T; Tsuneyoshi M
Mod Pathol; 1996 Mar; 9(3):253-60. PubMed ID: 8685224
[TBL] [Abstract][Full Text] [Related]
52. Assessment of proliferation index with MIB-1 as a prognostic factor in radiation therapy for cervical cancer.
Suzuki M; Tsukagoshi S; Saga Y; Ohwada M; Sato I
Gynecol Oncol; 2000 Nov; 79(2):300-4. PubMed ID: 11063661
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
[TBL] [Abstract][Full Text] [Related]
54. S100A5: a marker of recurrence in WHO grade I meningiomas.
Hancq S; Salmon I; Brotchi J; De Witte O; Gabius HJ; Heizmann CW; Kiss R; Decaestecker C
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):178-87. PubMed ID: 15043715
[TBL] [Abstract][Full Text] [Related]
55. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
Aghi MK; Carter BS; Cosgrove GR; Ojemann RG; Amin-Hanjani S; Martuza RL; Curry WT; Barker FG
Neurosurgery; 2009 Jan; 64(1):56-60; discussion 60. PubMed ID: 19145156
[TBL] [Abstract][Full Text] [Related]
56. [Detection of Ki-67 in liver biopsy specimens using monoclonal antibody to Mib-1].
Matsumoto K; Tanimoto K; Michitaka K; Furutani T; Nakaya M; Horiike N; Onji M
Rinsho Byori; 1999 Oct; 47(10):956-60. PubMed ID: 10590670
[TBL] [Abstract][Full Text] [Related]
57. Clear cell meningioma variant and clinical aggressiveness.
Pimentel J; Fernandes A; Pinto AE; Fonseca I; Moura Nunes JF; Lobo Antunes J
Clin Neuropathol; 1998; 17(3):141-6. PubMed ID: 9625306
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
Prayson RA; Mohan DS; Song P; Suh JH
Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
[TBL] [Abstract][Full Text] [Related]
59. [A case of recurrent convexity meningioma with malignant transformation 26 years after total tumor removal].
Ohta M; Takeshita I
No Shinkei Geka; 2001 Jan; 29(1):81-5. PubMed ID: 11218772
[TBL] [Abstract][Full Text] [Related]
60. Prediction of intracranial edema after radiosurgery of meningiomas.
Novotný J; Kollová A; Liscák R
J Neurosurg; 2006 Dec; 105 Suppl():120-6. PubMed ID: 18503344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]